Ropes Wealth Advisors’s Abiomed Inc ABMD Stock Holding History

Ropes Wealth Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-37	Closed	-$12K	–	852
2020 Q4	$12K	Sell	37 -46	-55%	-$12.7K	﹤0.01%	527
2020 Q3	$23K	Sell	83 -10	-11%	-$2.88K	﹤0.01%	424
2020 Q2	$22K	Hold	93	–	–	﹤0.01%	388
2020 Q1	$13K	Sell	93 -175	-65%	-$29.1K	﹤0.01%	402
2019 Q4	$46K	Sell	268 -31	-10%	-$5.75K	0.01%	342
2019 Q3	$53K	Hold	299	–	–	0.01%	334
2019 Q2	$78K	Hold	299	–	–	0.02%	298
2019 Q1	$85K	Buy	299 +268	+865%	+$89.1K	0.02%	282
2018 Q4	$10K	Hold	31	–	–	﹤0.01%	428
2018 Q3	$14K	Hold	31	–	–	﹤0.01%	438
2018 Q2	$13K	Hold	31	–	–	﹤0.01%	457
2018 Q1	$9K	Sell	31 -156	-83%	-$39.5K	﹤0.01%	469
2017 Q4	$35K	Hold	187	–	–	0.01%	380
2017 Q3	$32K	Buy	+187	New	+$28.3K	0.01%	369

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Ropes Wealth Advisors's ABMD Position: Q1 2021 in Review

Ropes Wealth Advisors sold out of Abiomed Inc (ABMD) in Q1 2021, closing a stake of 37 shares — an estimated $12K sold.

Ropes Wealth Advisors first reported a position in ABMD in Q3 2017 and held it in 14 quarters. The position peaked at $85K in Q1 2019. 487 funds tracked by Wall St. Rank hold ABMD as of Q1 2021.

Ropes Wealth Advisors reported no remaining Abiomed Inc position as of Q1 2021 after selling out during the quarter.
Ropes Wealth Advisors sold 37 Abiomed Inc shares in Q1 2021, an estimated $12K.
Ropes Wealth Advisors first reported a position in Abiomed Inc in Q3 2017 and held it in 14 quarters.
Ropes Wealth Advisors's Abiomed Inc position peaked at $85K in Q1 2019.
487 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2021.

Based on Ropes Wealth Advisors's 13F filing for Q1 2021, filed 12 May 2021.